Evidence map›Paper›PMID 42558092›Full record

ArticleJournal of medical extended reality2024

Sociodemographic Predictors of Clinical Effectiveness, Therapeutic Program Engagement, and Device Usability for an In-Home Virtual Reality Program for Chronic Low Back Pain: Secondary Analysis of a Randomized Controlled Trial.

Todd Maddox, Liesl Oldstone, Josh Sackman, Emily Judge, Roselani Maddox, Takisha Adair, Kelsey Ffrench, Charisse Y Sparks, Beth D Darnall

Abstract read
In one paragraph

Article in Journal of medical extended reality, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Todd MaddoxAppliedVR, Inc., Van Nuys, California, USA.ORCID https://orcid.org/0000-0003-1265-4960
Liesl OldstoneAppliedVR, Inc., Van Nuys, California, USA.
Josh SackmanAppliedVR, Inc., Van Nuys, California, USA.
Emily JudgeAppliedVR, Inc., Van Nuys, California, USA.
Roselani MaddoxAppliedVR, Inc., Van Nuys, California, USA.
Takisha AdairAppliedVR, Inc., Van Nuys, California, USA.
Kelsey FfrenchAppliedVR, Inc., Van Nuys, California, USA.
Charisse Y SparksInspire Medical Systems, Inc., Golden Valley, Minnesota, USA.
Beth D DarnallDepartment of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health care inequities are well-established in chronic pain care. Immersive digital therapeutics may transcend such barriers by offering in-home access with no Wi-Fi connectivity required, and easy to use, gaze-based navigation, and therapeutic delivery. The objective of this report is to determine whether clinical effectiveness, therapeutic program engagement, and virtual reality (VR) device usability of an Food and Drug Administration (FDA)-authorized, proprietary skills-based VR program for chronic pain (i.e., RelieVRx

Indexed as

chronic low back paincognitive behavioral therapyvirtual reality

Identifiers

PMID42558092
PMCPMC13387221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.